Participants were randomized to one of two experimental conditions (propranolol, placebo). Contraindications were checked and drugs were administered by a qualified clinician (AL). The experimenter was blind to drug group and unblinding only occurred after the study was completed. There were no group differences in sex, age, anxiety, or cardiac measures (Table 1). One participant (propranolol group) was excluded from the computational analysis owing to a high proportion of error responses, which could affect the Bayesian modeling.29

Participant Characteristics

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.